Nkarta: Grinding Lower, Trying To Find Support

Nkarta, Inc. (NASDAQ: NKTX ) is among a group of oncology-focused cell therapy outlets trying to make hay as the sun seems to be setting on the entire space. Political uncertainties , I have my PhD in biochemistry and have worked for years analyzing clinical trials and biotech companies. It is my passion to educate everyone possible on the science behind the businesses that we invest in, and it's my mission to help you do your due diligence and not get burned by the pitfalls of investing in this space. Anal ...